#1 Clinical Trials Search in Europe

Mometasone Furoate Monohydrate

Mometasone Furoate Monohydrate is a corticosteroid medication that has been studied in several clinical trials for its potential in treating various respiratory conditions. This article explores the use of this drug in clinical trials for conditions such as asthma, chronic rhinosinusitis, and seasonal allergic rhinitis. We’ll examine how it’s administered, its effectiveness compared to other treatments, and what researchers have learned about its benefits and potential side effects.

Table of Contents

What is Mometasone Furoate Monohydrate?

Mometasone Furoate Monohydrate is a corticosteroid medication used to treat various conditions affecting the nose and sinuses. It’s also known by the brand name Nasonex[1]. Corticosteroids are synthetic versions of hormones that your body naturally produces. They help reduce inflammation and allergic responses in your body.

What Conditions Does Mometasone Treat?

Mometasone is primarily used to treat the following conditions:

  • Seasonal Allergic Rhinitis: This is also known as hay fever, which causes symptoms like sneezing, runny nose, and nasal congestion during specific seasons[1].
  • Chronic Rhinosinusitis: This is a long-term inflammation of the nose and sinuses, causing symptoms like nasal congestion, facial pain, and reduced sense of smell[2].
  • Nasal Polyps: These are soft, painless, noncancerous growths on the lining of your nasal passages or sinuses[2].
  • Eosinophilic Esophagitis: This is a chronic immune system disease where a type of white blood cell (eosinophil) builds up in the lining of the tube that connects your mouth to your stomach (esophagus)[3].

How Does Mometasone Work?

Mometasone works by reducing inflammation in the nasal passages. It does this by suppressing the activity of certain cells in your immune system and reducing the production of inflammatory substances. This helps to alleviate symptoms such as nasal congestion, runny nose, and sneezing[4].

How is Mometasone Administered?

Mometasone is typically administered as a nasal spray. The most common dosage is 50 micrograms per spray. Depending on your condition and age, you may be instructed to use one or two sprays in each nostril once or twice daily[4]. In some cases, it may also be administered through nasal irrigation, where the medication is mixed with saline solution and used to rinse the nasal passages[2].

How Effective is Mometasone?

Mometasone has been shown to be effective in treating various nasal conditions. In clinical trials, it has demonstrated significant improvements in symptoms of seasonal allergic rhinitis compared to placebo. It’s also been shown to improve nasal congestion, runny nose, and other symptoms associated with chronic rhinosinusitis[1][2].

Clinical Studies on Mometasone

Several clinical studies have been conducted to evaluate the efficacy and safety of Mometasone:

  • A study compared Mometasone nasal spray to placebo in treating seasonal allergic rhinitis. The study found that Mometasone was significantly more effective in reducing nasal symptoms[1].
  • Another study evaluated the effectiveness of Mometasone nasal irrigation for chronic rhinosinusitis. This study aimed to compare the effectiveness of Mometasone delivered through nasal irrigation versus standard nasal spray[2].
  • A study investigated the use of Mometasone in treating eosinophilic esophagitis. This was a novel application of the medication, typically used for nasal conditions[3].

Potential Side Effects

While Mometasone is generally well-tolerated, like all medications, it can cause side effects in some people. Common side effects may include:

  • Headache
  • Nosebleeds
  • Throat irritation
  • Nasal burning or irritation

It’s important to discuss any side effects with your healthcare provider. They can help determine if the benefits of the medication outweigh the risks for your specific situation[4].

Aspect Details
Conditions Studied Asthma, Chronic Rhinosinusitis, Seasonal Allergic Rhinitis, Eosinophilic Esophagitis
Administration Methods Nasal Spray, Nasal Irrigation, Inhaler
Dosages Varies by study, typically 50 mcg per actuation for nasal sprays
Primary Outcomes Changes in symptom scores, lung function improvement, quality of life measures
Comparison Groups Placebo, Other corticosteroid formulations (e.g., Nasonex)
Study Designs Randomized, double-blind, placebo-controlled trials
Duration of Trials Typically 2-8 weeks, with some longer-term studies
Key Findings Generally superior to placebo in reducing symptoms and improving outcomes

FAQ

  • What conditions is Mometasone Furoate Monohydrate being studied for in clinical trials? Mometasone Furoate Monohydrate is being studied in clinical trials for several respiratory conditions, including asthma, chronic rhinosinusitis, seasonal allergic rhinitis, and eosinophilic esophagitis.
  • How is Mometasone Furoate Monohydrate typically administered in these trials? In the clinical trials, Mometasone Furoate Monohydrate is administered in various forms, including nasal sprays, nasal irrigation solutions, and inhalers. The dosage and frequency of administration vary depending on the specific study and condition being treated.
  • What are some of the primary outcomes being measured in these clinical trials? Primary outcomes being measured include changes in symptom scores (such as the Total Nasal Symptom Score), improvements in lung function for asthma patients, and changes in quality of life measures. Researchers also assess the safety profile and any potential side effects of the medication.
  • How does Mometasone Furoate Monohydrate compare to placebo in these trials? In many of the trials, Mometasone Furoate Monohydrate is compared to a placebo to determine its effectiveness. Generally, the active drug shows superior results in reducing symptoms and improving patient outcomes compared to the placebo.
  • Are there any notable side effects or safety concerns identified in these clinical trials? While specific side effects are not detailed in the provided trial summaries, corticosteroids like Mometasone Furoate Monohydrate can have potential side effects. The clinical trials aim to assess the safety profile of the medication, but patients should always consult with their healthcare provider about potential risks and benefits.

Ongoing Clinical Trials on Mometasone Furoate Monohydrate

  • Study on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen

    Recruiting

    3 1 1
    Investigated drugs:
    Bulgaria Czechia Germany Lithuania Poland Romania +1

Glossary

  • Chronic rhinosinusitis (CRS): A condition characterized by inflammation of the nasal passages and sinuses that lasts for 12 weeks or longer, causing symptoms such as nasal congestion, facial pain, and reduced sense of smell.
  • Seasonal allergic rhinitis: An allergic reaction to airborne substances (such as pollen) that occurs during specific times of the year, causing symptoms like sneezing, runny nose, and itchy eyes.
  • Eosinophilic esophagitis: A chronic immune system disease characterized by a buildup of white blood cells (eosinophils) in the lining of the esophagus, causing difficulty swallowing and food getting stuck.
  • Intranasal corticosteroids (INCS): A class of medications that are sprayed or inhaled into the nose to reduce inflammation in the nasal passages, commonly used to treat allergies and other nasal conditions.
  • Total Nasal Symptom Score (TNSS): A measure used in clinical trials to assess the severity of nasal symptoms, typically including factors such as congestion, runny nose, itching, and sneezing.
  • Placebo-controlled trial: A type of clinical study where some participants receive an inactive substance (placebo) instead of the active drug, allowing researchers to compare the true effects of the medication.
  • Bioequivalence: The property of two drug products having the same active ingredient, dosage form, strength, and route of administration to be pharmaceutically equivalent and to have comparable bioavailability.

References

  1. https://clinicaltrials.gov/study/NCT02125253
  2. https://clinicaltrials.gov/study/NCT03705793
  3. https://clinicaltrials.gov/study/NCT02113267
  4. https://clinicaltrials.gov/study/NCT01118312